| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |